Technology Healthcare Big Data Analytics

What Technology Healthcare Big Data Analytics does

THB (Technology Healthcare Big Data Analytics), legally Sekhmet Technologies Private Limited, is a healthcare data-technology and analytics company founded in 2015 and headquartered in Gurgaon, India, with regional operations in Dubai for EMEA. It sells enterprise software and analytics services to pharmaceutical companies, hospital and diagnostic chains, and healthcare professionals (HCPs), serving clients across six countries including named accounts such as Sun Pharma, Cipla, Glenmark, Sanofi, Pfizer, AstraZeneca, MSD, Biocon, Fortis, Max Healthcare, and Shalby.

The platform is structured around four pillars: a Close-Circuit Coordinated Care Platform with 15+ modules, Real World Clinical Evidence (including a peer-reviewed sub-brand called ERWE Journal), New-Age HCP Outreach, and THB Growth Insights (modules PERCEPT, THOR, CapPredict). Underlying technology includes 10+ proprietary data processing engines covering NLP, de-identification, and ICD/Loinc coding; ML-led recommendation engines with 1,000+ pre-integrated clinical rule engines; predictive analytics with claimed 95%+ Rx share forecasting accuracy; and integrations with 30+ external hospital information systems. The proprietary deidentified repository covers 60 million+ patient lives, 1 billion+ clinical parameters, 25+ therapy areas, and draws from 5,000+ partner centers and a 600,000+-doctor engagement network.

The business model is enterprise B2B with multi-year contracts, combining SaaS subscriptions for analytics and outreach modules, professional services for evidence generation and clinical research, and transaction-linked usage in coordinated-care workflows. Go-to-market is direct enterprise sales, supported by deep clinical/technical talent (200+ technologists, 100+ researcher partners, 30+ advisors). The company is private and venture-backed; its only disclosed institutional funding is a US$20M round in May 2023 led by Filter Capital and Edelweiss Discovery Fund Series-I, with prior participation from Blume Ventures, HealthQuad, Cornerstone, Health Capital, KOIS Invest, Di Global, and Sealink Capital.

Name

Technology Healthcare Big Data Analytics

Legal name

Sekhmet Technologies Private Limited

Website

https://thb.group

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

251–500 employees

Short description

THB (Sekhmet Technologies) is a healthcare analytics company that sells enterprise SaaS and real-world evidence services to pharma, hospital, and HCP clients across six countries, built on a proprietary deidentified data repository of 60M+ patient lives.

Ownership category

akta.pro rank

Product category

Healthcare Data Analytics Platform

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Prepackaged Software (7372), Services-Health Services (8000)

akta.pro primary industry

Cost of Care, Spend Analytics & Financial Performance Management (HLACAHAJ)

akta.pro secondary industries

Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO), Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN), Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)

Keywords

• Healthcare data analytics
• Real-world evidence
• HCP engagement platform
• Patient care coordination
• Clinical decision support

Headquarters

HQ city

Gurugram

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Enterprise SaaS/Platform Subscriptions: B2B enterprise software platform providing subscription-based access to healthcare data analytics, RWE generation, HCP engagement, and patient coordination solutions. Platform deals with healthcare enterprises including pharma companies, hospitals, and diagnostic chains.
2. Professional Services: End-to-end research and evidence generation services including clinical operations, biostatistics, medical writing, and publications support

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

THB builds and operates a healthcare data-technology and analytics platform that processes clinical data from 5,000+ partner centres covering 60mn+ deidentified patient lives. It delivers four solution pillars to pharmaceutical companies, hospitals, and diagnostic chains: a Close-Circuit Coordinated Care Platform (15+ modules), Real World Clinical Evidence generation (Medical Affairs services), New-Age HCP Outreach (5-module omni-channel platform), and THB Growth Insights (PERCEPT, THOR, CapPredict analytics). Revenue is generated via multi-year enterprise platform subscriptions plus professional services for clinical operations, biostatistics, and publications.

Product overview

THB operates as a Healthcare Data-Technology and Data-Analytics Platform organized around four core pillars: Close-Circuit Coordinated Care Platform (15+ modules), Real World Clinical Evidence (Medical Affairs + ERWE Journal), New-Age HCP Outreach (Orchestrated HCP Engagement with 5 modules), and THB Growth Insights (PERCEPT, THOR, CapPredict). The platform is built by Sekhmet Technologies Private Limited and processes data across 60 million+ patient lives through 5000+ partner centers. The offering combines a unified data layer with AI-powered recommendation engines, NLP-based clinical data processing, and 200+ integrated dashboards, spanning patient engagement (Clinical CRM, Patient NPS, Patient Support Bots), healthcare professional outreach (Digital Sales Force, Digital Medical Representative), and business intelligence (therapy intelligence, oncology insights, business intelligence). The company also offers mobile applications including Clinytics, PEP, DMR, VMR, and Phlebex.

Differentiator

Problem solved

Functional benefit

Products and services

• Close-Circuit Coordinated Care Platform

Quantifiable outcome

• 2X improvement in salesforce productivity
• +9 more outcomes

Named customers28 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature8 records

Scale indicators19 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Axtria: US-headquartered (with major India operations) data analytics and AI software company focused on pharma commercialization, sales operations, and HCP engagement. Directly comparable to THB's PERCEPT, HCP outreach, and therapy intelligence offerings for global pharma clients.
• Indegene: India-headquartered digital commercialization partner for global pharma and biotech, offering HCP engagement, real-world evidence, and medical affairs services. Closely comparable to THB across pharma RWE, medical affairs, and orchestrated HCP outreach.
• Innovaccer: Healthcare data platform company offering unified patient records, population health management, and AI-driven analytics for providers and payers. Comparable to THB's Close-Circuit Coordinated Care platform and deidentified data repository approach.
• ZS Associates: Global management consulting and technology firm with deep pharma commercial analytics practice, including sales force effectiveness, prescriber analytics, and AI-driven next-best-action recommendations. Comparable to THB's therapy intelligence and digital MR capabilities.
• Trinity Life Sciences: Life sciences strategy and analytics firm offering real-world evidence, evidence generation, and commercial analytics to pharma. Directly comparable to THB's medical affairs, RWE, and PERCEPT therapy intelligence solutions.
• CitiusTech: Healthcare technology services and analytics firm serving providers, payers, and life sciences with BI, value-based care, and clinical data management solutions. Comparable to THB's CapPredict BI and provider-focused offerings.

Broad incumbents

• IQVIA: Global leader in healthcare data, advanced analytics, RWE, and clinical research services for life sciences. Overlaps broadly with THB's RWE, biostatistics, and HCP engagement offerings but at significantly larger scale with deeper longitudinal data assets.
• ICON plc: Global CRO and healthcare intelligence firm offering real-world evidence, biostatistics, and post-marketing studies. Overlaps with THB's RWE/medical affairs offerings as an established incumbent with global reach.
• Parexel: Global CRO with established real-world evidence, biostatistics, and medical affairs services for pharma and biotech. Comparable to THB's Real World Clinical Evidence platform as a larger, incumbent provider.

Emerging players

• Truveta: US-based emerging health data platform aggregating deidentified patient records from large US health systems for RWE and analytics. Comparable to THB's data-repository-driven RWE model but with a US-centric data footprint and emerging scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/thbinsights

Revenue estimate

Valuation estimate

Number of profiles

Profiles20 records

Funding overview

Funding rounds1 record

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Technology Healthcare Big Data Analytics